Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more
Zhejiang DiAn Diagnostics Co (300244) - Total Assets
Latest total assets as of September 2025: CN¥14.77 Billion CNY
Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) holds total assets worth CN¥14.77 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang DiAn Diagnostics Co - Total Assets Trend (2008–2024)
This chart illustrates how Zhejiang DiAn Diagnostics Co’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhejiang DiAn Diagnostics Co - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang DiAn Diagnostics Co's total assets of CN¥14.77 Billion consist of 75.4% current assets and 24.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.6% |
| Accounts Receivable | CN¥7.52 Billion | 47.7% |
| Inventory | CN¥1.63 Billion | 10.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥58.42 Million | 0.4% |
| Goodwill | CN¥469.97 Million | 3.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Zhejiang DiAn Diagnostics Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang DiAn Diagnostics Co's current assets represent 75.4% of total assets in 2024, a decrease from 75.8% in 2008.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2024, down from 12.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 47.7% of total assets.
Zhejiang DiAn Diagnostics Co Competitors by Total Assets
Key competitors of Zhejiang DiAn Diagnostics Co based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Zhejiang DiAn Diagnostics Co - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Zhejiang DiAn Diagnostics Co generates 0.77x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Zhejiang DiAn Diagnostics Co is currently not profitable relative to its asset base.
Zhejiang DiAn Diagnostics Co - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.74 | 2.61 | 1.47 |
| Quick Ratio | 2.36 | 2.24 | 1.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥7.01 Billion | CN¥ 7.89 Billion | CN¥ 2.61 Billion |
Zhejiang DiAn Diagnostics Co - Advanced Valuation Insights
This section examines the relationship between Zhejiang DiAn Diagnostics Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.41 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -12.0% |
| Total Assets | CN¥15.79 Billion |
| Market Capitalization | $1.14 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang DiAn Diagnostics Co's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Zhejiang DiAn Diagnostics Co's assets decreased by 12.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Zhejiang DiAn Diagnostics Co (2008–2024)
The table below shows the annual total assets of Zhejiang DiAn Diagnostics Co from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥15.79 Billion | -12.00% |
| 2023-12-31 | CN¥17.94 Billion | -14.80% |
| 2022-12-31 | CN¥21.06 Billion | +35.03% |
| 2021-12-31 | CN¥15.59 Billion | +25.77% |
| 2020-12-31 | CN¥12.40 Billion | +15.34% |
| 2019-12-31 | CN¥10.75 Billion | +0.79% |
| 2018-12-31 | CN¥10.67 Billion | +44.33% |
| 2017-12-31 | CN¥7.39 Billion | +29.25% |
| 2016-12-31 | CN¥5.72 Billion | +149.44% |
| 2015-12-31 | CN¥2.29 Billion | +106.74% |
| 2014-12-31 | CN¥1.11 Billion | +36.63% |
| 2013-12-31 | CN¥811.49 Million | +14.92% |
| 2012-12-31 | CN¥706.15 Million | +17.56% |
| 2011-12-31 | CN¥600.69 Million | +156.43% |
| 2010-12-31 | CN¥234.25 Million | +31.09% |
| 2009-12-31 | CN¥178.69 Million | +61.25% |
| 2008-12-31 | CN¥110.82 Million | -- |